Urinary tract infections (UTI) continue to be the commonest nosocomial infections. UTI is often treated with different broadspectrum antibiotics when one with a narrow spectrum of activity may be appropriate. The extensive use of antimicrobial agents have invariably resulted in development of antibiotic resistance, which in recent years has become a major problem worldwide.
AIM AND OBJECTIVES1) Aim of the study is to isolate bacteria that cause urinary tract infections (UTI). 2) To understand resistance pattern of uropathogens which assist in choosing empirical therapy for urinary tract infections (UTI).
MATERIALS AND METHODSThe present study was conducted on patients with clinically suspected UTI attending our hospital. 500 urine samples were collected from these patients and were tested. All the isolates were identified according to the standard biochemical tests and antibiotic susceptibility testing was done by disc diffusion method.
RESULTS160 isolates of uropathogens isolated from 500 clinical samples of urine were included in this study. Among 160 isolates (major bacterial isolates from UTI), the predominant isolate was Escherichia coli and the second most common organism was Klebsiella spp. followed by CONS, Candida spp., Pseudomonas spp., Enterococcus spp., Acinetobacter spp., Staphylococcus aureus and Enterobacter. 25.62% of organisms were isolated from male patients and 74.37% were isolated from female patients. This showed a female predominance. Age group between 21-30 showed highest incidence of UTI followed by 1-10, 11-20, 31-40, 41-50, 61-75, 51-60 and ≥75. This showed more incidence of UTI among sexually active population. Escherichia coli predominated in hospital as well as in community patients. The second most common was Klebsiella spp. which predominated in hospitalised patients. Among the community patients, Escherichia coli predominated followed by Klebsiella spp., Enterococcus spp., CONS and Pseudomonas spp. In the present study, it was observed that ESBL production was 91.04% in Escherichia coli, 77.77% in Klebsiella spp., in Pseudomonas spp. it was 50%. MBL production was observed in 2.98% of Escherichia coli, 50% of Pseudomonas spp., 16.66% of Klebsiella spp. In this study, Gram-negative bacilli isolated from UTI were highly sensitive to amikacin and imipenem, and Grampositive organisms were sensitive to vancomycin and imipenem except Enterococci which showed 100% resistance to vancomycin.